Alican Dalkilic — TMS Medicare billing
M.D. · Psychiatry · Cherry Hill, NJ
TMS provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Services (2024)
484
Patient bounds
25–50
Services per patient (bounds)
9.7–19.4
Estimated Medicare paid
$82,026
National provider median $51,810
National peer context
#230 of 391 published TMS providers by screening score/payment in 2024 · 0.23% of national published TMS payment. This rank is not a clinical assessment.
Peer evidence
Screening score 0 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
No NPI match in the saved OIG LEIE copy—not a clearance.
Year-over-year Medicare payments
CMS billing detail — 2024
Fetched 2026-11-07T23:23:37.341Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90867 Initial treatment + motor-threshold determination | 13 | 13–13 | 1.0–1.0 | $2,857 |
| 90868 Subsequent treatment | 459 | 25–25 | 18.4–18.4 | $76,695 |
| 90869 Motor-threshold re-determination + treatment | 12 | 12–12 | 1.0–1.0 | $2,474 |
Peer evidence
Screening score 0 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
CMS billing detail — 2023
Fetched 2026-11-07T23:23:27.130Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90867 Initial treatment + motor-threshold determination | 17 | 14–14 | 1.2–1.2 | $2,959 |
| 90868 Subsequent treatment | 476 | 22–22 | 21.6–21.6 | $81,352 |
| 90869 Motor-threshold re-determination + treatment | 21 | 11–11 | 1.9–1.9 | $3,508 |
Peer evidence
Screening score 8 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
Medicare Part B fee-for-service only; Medicare Advantage, Medicaid and commercial claims are excluded. CMS suppresses provider-code rows with fewer than 11 beneficiaries. Patient counts overlap across codes and settings; bounds are not unique national patients. Annual aggregates cannot establish treatment courses, failure, medical necessity, duplicate visits or fraud. Coverage varies by Medicare contractor; no Spravato dosing thresholds are applied.
